Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

BACKGROUND: Chemotherapy remains the standard care for HER2 mutated advanced non-small cell lung cancer (NSCLC) even though several targeted drugs showed promising results in preliminary stages. This study aimed to investigate the association of mutation variants with clinical features and the effic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transl Lung Cancer Res
Главные авторы: Yang, Shuo, Wang, Yan, Zhao, Chao, Li, Xuefei, Liu, Qian, Mao, Shiqi, Liu, Yiwei, Yu, Xiaofei, Wang, Wanying, Tian, Qinrun, Pan, Yingying, Xiong, Anwen, Chen, Bin, Gao, Guanghui, Li, Wei, He, Yayi, Wu, Fengying, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947396/
https://ncbi.nlm.nih.gov/pubmed/33718019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-559
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы